IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31)
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) of $221.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-07-23.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax · last filed 2013-07-23
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2013-06-30 was $221.00K, a 68.34% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $8.00K.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-12-31 was -$189.00K, a 1818.18% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-09-30 was -$395.00K, a 169.91% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2012 was -$1.62M, a 183.62% decline from fiscal 2011.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2011 was $1.94M, a 217.16% increase from fiscal 2010.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2010 was $612.00K.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | $221.00K 10-Q · filed 2013-07-23 | $213.00K 10-Q · filed 2013-07-23 | $40.00K derived: sum of 3 quarters · filed 2013-07-23 | -$355.00K derived: sum of 4 quarters · filed 2013-07-23 |
| 2013-03-31 | $8.00K 10-Q · filed 2013-04-23 | -$181.00K derived: sum of 2 quarters · filed 2013-04-23 | -$576.00K derived: sum of 3 quarters · filed 2013-04-23 | $122.00K derived: sum of 4 quarters · filed 2013-07-23 |
| 2012-12-31 | -$189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$584.00K derived: sum of 2 quarters · filed 2013-02-19 | $114.00K derived: sum of 3 quarters · filed 2013-07-23 | -$1.62M 10-K · filed 2013-02-19 |
| 2012-09-30 | -$395.00K 10-Q · filed 2012-10-19 | $303.00K derived: sum of 2 quarters · filed 2013-07-23 | -$1.43M 10-Q · filed 2012-10-19 | -$27.00K derived: sum of 4 quarters · filed 2013-07-23 |
| 2012-06-30 | $698.00K 10-Q · filed 2013-07-23 | $1.04M 10-Q · filed 2013-07-23 | $368.00K derived: sum of 3 quarters · filed 2013-07-23 | $933.00K derived: sum of 4 quarters · filed 2013-07-23 |
| 2012-03-31 | -$341.00K 10-Q · filed 2013-04-23 | -$330.00K derived: sum of 2 quarters · filed 2013-04-23 | $235.00K derived: sum of 3 quarters · filed 2013-04-23 | -$605.00K derived: sum of 4 quarters · filed 2013-04-23 |
| 2011-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $576.00K derived: sum of 2 quarters · filed 2013-02-19 | -$264.00K derived: sum of 3 quarters · filed 2013-02-19 | $1.94M 10-K · filed 2013-02-19 |
| 2011-09-30 | $565.00K 10-Q · filed 2012-10-19 | -$275.00K derived: sum of 2 quarters · filed 2012-10-19 | $1.93M 10-Q · filed 2012-10-19 | |
| 2011-06-30 | -$840.00K 10-Q · filed 2012-07-20 | -$1.36M 10-Q · filed 2012-07-20 | ||
| 2010-12-31 | $612.00K 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |